methyldopa has been researched along with Cystic Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BJOERK, S | 1 |
| Berman, LB; Cangiano, JL; Gould, A; Vertes, V | 1 |
1 review(s) available for methyldopa and Cystic Kidney Diseases
| Article | Year |
|---|---|
CHEMISTRY AND THERAPY OF MALIGNANT HYPERTENSION.
Topics: Aldosterone; Angiotensins; Antihypertensive Agents; Blood Vessels; Cushing Syndrome; Glomerulonephritis; Humans; Hypertension; Hypertension, Malignant; Kidney; Kidney Diseases, Cystic; Methyldopa; Pheochromocytoma; Pyelonephritis; Renal Artery Obstruction; Renin; Water-Electrolyte Balance | 1963 |
1 other study(ies) available for methyldopa and Cystic Kidney Diseases
| Article | Year |
|---|---|
Hypertension in end-stage renal disease.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Black People; Blood Pressure; Body Weight; Chronic Disease; Diabetic Nephropathies; Edema; Extracellular Space; Female; Glomerulonephritis; Guanethidine; Humans; Hydralazine; Hypertension, Renal; Kidney; Kidney Diseases; Kidney Diseases, Cystic; Male; Methyldopa; Middle Aged; Nephrectomy; Nephritis, Interstitial; Peritoneal Dialysis; Pyelonephritis; Renin; Water-Electrolyte Balance; White People | 1969 |